Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Nohara (kumamoto, Japan). Type 2 diabetes-related “pulmonary insulin resistance” as a novel mechanism that complicates COPD phenotypes in mice. 379

Member's Comments

No comment yet.

Related content which might interest you: A potential role for insulin resistance in experimental pulmonary hypertension Source: Eur Respir J 2013; 41: 861-871 Year: 2013 Insulin therapy increases airway responsiveness in type 2 diabetes patients Source: Annual Congress 2008 - Cough and airway hyperresponsiveness Year: 2008 Inadequate glucose control in type 2 diabetes is associated with impaired lung function and with systemic inflammation Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009 Inhaled insulin does not induce immediate airway responsiveness in patients with type 1 diabetes mellitus Source: Eur Respir J 2005; 26: Suppl. 49, 582s Year: 2005 Evaluation of association between COPD and metabolic syndrome, and insulin resistance Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 Presentations and treatment response of pulmonary tuberculosis in type 2 diabetes mellitus Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012 Peripheral insulin resistance accounts for impaired glucose tolerance and is associated with systemic inflammation in COPD Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 Is there any characteristics difference between pulmonary tuberculosis patients with and without diabetes mellitus type 2? Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities Year: 2009 Metabolic syndrome and diabetes mellitus in COPD Source: Eur Respir Mon 2013; 59: 117-134 Year: 2013 COPD prevalence and severity is associated to type 2 diabetes mellitus complications and lack of glycometabolic control Source: Annual Congress 2008 - COPD and comorbidities Year: 2008 The influence of diabetes type 2 (D2) on pulmonary hypertension (PH) in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 60s Year: 2005 Shared mechanisms of multimorbidity in COPD, atherosclerosis and type-2 diabetes: the neutrophil as a potential inflammatory target Source: Eur Respir Rev, 29 (155) 190102; 10.1183/16000617.0102-2019 Year: 2020 Hyperinsulinemia due to altered insulin secretion contributes to insulin resistance in chronic intermittent hypoxia independently of obesity Source: International Congress 2019 – Insights into the pathophysiology of sleep-disordered breathing Year: 2019 Prevention and mechanism of undesirable adverse reactions in patients with pulmonary tuberculosis with extensive drug-resistance (XDR) combined with type 2 diabetes Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019 Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Insulin resistance modifies the association between obesity and current asthma in adults Source: Eur Respir J 2016; 48: 403-410 Year: 2016 Pulmonary function of inhaled human insulin (Exubera®) in patients with type 2 diabetes: results from a 2-year study using standardized methodology Source: Eur Respir J 2006; 28: Suppl. 50, 742s Year: 2006 Evidence of early abnormal airways’ inflammation in children with type 1 diabetes Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches Year: 2021 Death rate of COPD patients and combination with type 2 diabetes Source: Eur Respir J 2007; 30: Suppl. 51, 79s Year: 2007 Newly detected pulmonary tuberculosis in patients combined with diabetes mellitus and without it. Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019